Kaplan D B, Kwon C C, Marin M L, Hollier L H
Mount Sinai Medical Center, Cleveland, Ohio, USA.
J Vasc Surg. 1999 Sep;30(3):407-15. doi: 10.1016/s0741-5214(99)70067-4.
The endovascular repair of abdominal aortic aneurysms (AAAs) has been suggested as an alternative to conventional aortic reconstruction. The presence of anomalous renal vascular anatomy frequently necessitates special planning during conventional aortic replacement and may also create unique challenges for endovascular repair. We analyzed our experience with 24 patients with variant renal vascular anatomies who underwent treatment with aortic endografts to determine the safety and efficacy of this technique in this population.
During a 6-year period, 204 patients underwent aortic endograft procedures, 24 (11.8%) of whom had variations in renal vascular anatomy. There were 19 men and five women. Each of the 24 patients had variant renal vascular anatomy, which was defined by the presence of multiple renal arteries (n = 32), with or without a renal parenchymal anomaly (horseshoe or solitary pelvic kidney). Twenty patients underwent aneurysm repair with balloon expandable polytetrafluoroethylene grafts, and the remaining patients underwent endograft placement with self-expanding attachment systems. Eighteen patients underwent exclusion and presumed thrombosis of anomalous renal branches to effectively attach the aortic endograft. The decision to sacrifice a supernumerary artery was made on the basis of the vessel size (<3 mm), the absence of coexisting renal insufficiency, and the expectation for successful aneurysm exclusion.
The successful exclusion of the AAAs was achieved in all the patients, with the loss of a total of 17 renal artery branches in 12 patients. Small segmental renal infarcts (<20%) were detected in only six of the 12 patients with follow-up computed tomographic scan results, despite angiographic evidence of vessel occlusion at the time of endografting. No evidence of new onset hypertension or changes in antihypertensive medication was seen in this group. No retrograde endoleaks were detected through the excluded renal branches on late follow-up computed tomographic scans. Serum creatinine levels before and after endografting were unchanged after the exclusion of the AAA in all but one patient with multiple renal branches. One patient had a transient rise in serum creatinine level presumed to be caused by contrast nephropathy.
On the basis of this experience, we recommend the consideration of endovascular grafting for patients with AAAs and anomalous renal vessels when the main renal vascular anatomy can be preserved and when the loss of only small branches (<3 mm) is necessitated in patients with otherwise normal renal functions.
腹主动脉瘤(AAA)的血管腔内修复已被提议作为传统主动脉重建的替代方法。异常肾血管解剖结构的存在常常使传统主动脉置换术需要特殊规划,并且也可能给血管腔内修复带来独特挑战。我们分析了24例具有变异肾血管解剖结构且接受主动脉内移植物治疗的患者的经验,以确定该技术在这一人群中的安全性和有效性。
在6年期间,204例患者接受了主动脉内移植物手术,其中24例(11.8%)存在肾血管解剖结构变异。男性19例,女性5例。24例患者均有变异肾血管解剖结构,定义为存在多条肾动脉(n = 32),伴或不伴有肾实质异常(马蹄肾或孤立盆腔肾)。20例患者用球囊扩张聚四氟乙烯移植物进行动脉瘤修复,其余患者用自膨式附着系统进行内移植物置入。18例患者对异常肾分支进行封堵并假定血栓形成,以有效附着主动脉内移植物。根据血管大小(<3 mm)、不存在并存肾功能不全以及成功排除动脉瘤的预期来决定是否牺牲多余动脉。
所有患者均成功排除AAA,12例患者共损失17条肾动脉分支。尽管在植入内移植物时血管造影显示血管闭塞,但在12例接受随访计算机断层扫描的患者中,只有6例检测到小的节段性肾梗死(<20%)。该组未见新发高血压或降压药物变化的证据。在晚期随访计算机断层扫描中,未通过被封堵的肾分支检测到逆行内漏。除1例有多条肾分支的患者外,在排除AAA后,所有患者植入内移植物前后的血清肌酐水平均未改变。1例患者血清肌酐水平短暂升高,推测是由造影剂肾病引起。
基于这一经验,我们建议,对于AAA合并异常肾血管的患者,当主要肾血管解剖结构可保留且肾功能正常的患者仅需牺牲小分支(<3 mm)时,可考虑血管腔内植入术。